Your browser doesn't support javascript.
loading
Chimeric Antigen Receptor T Cells as Salvage Therapy for Post-Chimeric Antigen Receptor T Cell Failure.
Holland, Elizabeth M; Yates, Bonnie; Steinberg, Seth M; Yuan, Constance M; Wang, Hao-Wei; Annesley, Colleen; Shalabi, Haneen; Stroncek, David; Fry, Terry J; Krueger, Joerg; Jacoby, Elad; Hsieh, Emily; Bhojwani, Deepa; Gardner, Rebecca A; Maude, Shannon L; Shah, Nirali N.
Afiliación
  • Holland EM; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Yates B; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Steinberg SM; Biostatistics and Data Management Section, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Yuan CM; Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Wang HW; Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Annesley C; Division of Hematology and Oncology University of Washington, Seattle Children's Hospital, Seattle, Washington.
  • Shalabi H; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Stroncek D; Center for Cellular Engineering, National Institutes of Health Clinical Center, Bethesda, Maryland.
  • Fry TJ; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland; University of Colorado Anschutz Medical Campus and Center for Cancer and Blood Disorders, Children's Hospital of Colorado, Aurora, Colorado.
  • Krueger J; Bone Marrow Transplant/Cell Therapy Section, Division of Hematology/Oncology, SickKids, Toronto, Ontario, Canada.
  • Jacoby E; Pediatric Hemato-Oncology, Sheba Medical Center and Tel Aviv University, Tel Aviv, Israel.
  • Hsieh E; Hematology/Oncology, Cancer and Blood Disease Institute, Children's Hospital Los Angeles, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, California.
  • Bhojwani D; Hematology/Oncology, Cancer and Blood Disease Institute, Children's Hospital Los Angeles, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, California.
  • Gardner RA; Division of Hematology and Oncology University of Washington, Seattle Children's Hospital, Seattle, Washington.
  • Maude SL; Division of Oncology, Cell Therapy and Transplant Section, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
  • Shah NN; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. Electronic address: nirali.shah@nih.gov.
Transplant Cell Ther ; 29(9): 574.e1-574.e10, 2023 09.
Article en En | MEDLINE | ID: mdl-37394115

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia-Linfoma Linfoblástico de Células Precursoras B / Receptores Quiméricos de Antígenos Tipo de estudio: Prognostic_studies Límite: Adolescent / Adult / Child / Child, preschool / Humans Idioma: En Revista: Transplant Cell Ther Año: 2023 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia-Linfoma Linfoblástico de Células Precursoras B / Receptores Quiméricos de Antígenos Tipo de estudio: Prognostic_studies Límite: Adolescent / Adult / Child / Child, preschool / Humans Idioma: En Revista: Transplant Cell Ther Año: 2023 Tipo del documento: Article Pais de publicación: Estados Unidos